Industry Thought Leader Darius Pillsbury Joins ValSource

Darius Pillsbury has joined ValSource as a Senior Consultant. He brings more than 25 years of industry experience in biopharmaceutical manufacturing.

“Darius is a true thought leader in the design and validation of Cell & Gene Therapy aseptic process manufacturing,” commented Chief Operating Officer Hal Baseman.  “His years of expertise in biopharmaceutical manufacturing and quality will greatly benefit our clients and add to the strength of the ValSource team.”

Prior to joining ValSource, Darius led the Validation and Quality Lifecycle Management group at Adaptimmune, where he was responsible for the development and management of multiple Quality/CMC programs, including the Process Validation lifecycle approach for vein-to-vein processes used in the manufacture of autologous T-cell products, Quality Risk Management, Change Management, and Qualification of GMP systems (Equipment/Facilities/Utilities).

A current member of the PDA task force for developing standard on cryopreservation of cells for use in cell therapies and regenerative medicine manufacturing, Darius has presented on multiple topics at PDA annual meetings for Cell & Gene Therapy. He previously worked on PDA task force for Technical Report #60-2, Process Validation annex and the review of EU Annex 1 revision, as well as with the BioProcess Systems Alliance (BPSA) on the development of technical white papers for the implementation of single-use systems used in cell and gene therapy products.

Darius can be reached at dpillsbury@valsource.com.